Biorelevant release testing of biodegradable microspheres intended for intra-articular administration

Giulia Magri, Francesca Selmin, Francesco Cilurzo, Nikoletta Fotaki

Research output: Contribution to journalArticle

Abstract

Characterization of controlled release formulations used for intra-articular (IA) drug administration is challenging. Bio-relevant synovial fluids (BSF), containing physiologically relevant amounts of hyaluronic acid, phospholipids and proteins, were recently proposed to simulate healthy and osteoarthritic conditions. This work aims to evaluate the performance of different controlled release formulations of methylprednisolone (MP) for IA administration, under healthy and disease states simulated conditions. Microspheres differed in grade of poly(lactide-co-glycolide) and in the theoretical drug content (i.e. 23 or 30% w/w). Their performance was compared with the commercially available suspension of MP acetate (MPA). Under osteoarthritic state simulated condition, proteins increased the MPA release and reduced the MPA hydrolysis rate, over 48 h. Regarding microspheres, the release patterns over 40 days were significantly influenced by the composition of BSF. The pattern of the release mechanism and the amount released was affected by the presence of proteins. Protein concentration affected the release and the concentration used is critical, particularly given the relevance of the concentrations to target patient populations, i.e. patients with osteoarthritis.

Original languageEnglish
Pages (from-to)115-122
Number of pages8
JournalEuropean Journal of Pharmaceutics and Biopharmaceutics
Volume139
Early online date21 Mar 2019
DOIs
Publication statusPublished - 1 Jun 2019

Keywords

  • Biorelevant synovial fluids
  • Corticosteroids
  • Hyaluronic acid
  • Intra-articular
  • Methylprednisolone
  • Microspheres
  • PLGA
  • Proteins
  • Release testing

ASJC Scopus subject areas

  • Biotechnology
  • Pharmaceutical Science

Cite this

Biorelevant release testing of biodegradable microspheres intended for intra-articular administration. / Magri, Giulia; Selmin, Francesca; Cilurzo, Francesco; Fotaki, Nikoletta.

In: European Journal of Pharmaceutics and Biopharmaceutics, Vol. 139, 01.06.2019, p. 115-122.

Research output: Contribution to journalArticle

@article{9498ddc067124597b628c72ee823f782,
title = "Biorelevant release testing of biodegradable microspheres intended for intra-articular administration",
abstract = "Characterization of controlled release formulations used for intra-articular (IA) drug administration is challenging. Bio-relevant synovial fluids (BSF), containing physiologically relevant amounts of hyaluronic acid, phospholipids and proteins, were recently proposed to simulate healthy and osteoarthritic conditions. This work aims to evaluate the performance of different controlled release formulations of methylprednisolone (MP) for IA administration, under healthy and disease states simulated conditions. Microspheres differed in grade of poly(lactide-co-glycolide) and in the theoretical drug content (i.e. 23 or 30{\%} w/w). Their performance was compared with the commercially available suspension of MP acetate (MPA). Under osteoarthritic state simulated condition, proteins increased the MPA release and reduced the MPA hydrolysis rate, over 48 h. Regarding microspheres, the release patterns over 40 days were significantly influenced by the composition of BSF. The pattern of the release mechanism and the amount released was affected by the presence of proteins. Protein concentration affected the release and the concentration used is critical, particularly given the relevance of the concentrations to target patient populations, i.e. patients with osteoarthritis.",
keywords = "Biorelevant synovial fluids, Corticosteroids, Hyaluronic acid, Intra-articular, Methylprednisolone, Microspheres, PLGA, Proteins, Release testing",
author = "Giulia Magri and Francesca Selmin and Francesco Cilurzo and Nikoletta Fotaki",
year = "2019",
month = "6",
day = "1",
doi = "10.1016/j.ejpb.2019.03.019",
language = "English",
volume = "139",
pages = "115--122",
journal = "European Journal of Pharmaceutics and Biopharmaceutics",
issn = "0939-6411",
publisher = "Elsevier",

}

TY - JOUR

T1 - Biorelevant release testing of biodegradable microspheres intended for intra-articular administration

AU - Magri, Giulia

AU - Selmin, Francesca

AU - Cilurzo, Francesco

AU - Fotaki, Nikoletta

PY - 2019/6/1

Y1 - 2019/6/1

N2 - Characterization of controlled release formulations used for intra-articular (IA) drug administration is challenging. Bio-relevant synovial fluids (BSF), containing physiologically relevant amounts of hyaluronic acid, phospholipids and proteins, were recently proposed to simulate healthy and osteoarthritic conditions. This work aims to evaluate the performance of different controlled release formulations of methylprednisolone (MP) for IA administration, under healthy and disease states simulated conditions. Microspheres differed in grade of poly(lactide-co-glycolide) and in the theoretical drug content (i.e. 23 or 30% w/w). Their performance was compared with the commercially available suspension of MP acetate (MPA). Under osteoarthritic state simulated condition, proteins increased the MPA release and reduced the MPA hydrolysis rate, over 48 h. Regarding microspheres, the release patterns over 40 days were significantly influenced by the composition of BSF. The pattern of the release mechanism and the amount released was affected by the presence of proteins. Protein concentration affected the release and the concentration used is critical, particularly given the relevance of the concentrations to target patient populations, i.e. patients with osteoarthritis.

AB - Characterization of controlled release formulations used for intra-articular (IA) drug administration is challenging. Bio-relevant synovial fluids (BSF), containing physiologically relevant amounts of hyaluronic acid, phospholipids and proteins, were recently proposed to simulate healthy and osteoarthritic conditions. This work aims to evaluate the performance of different controlled release formulations of methylprednisolone (MP) for IA administration, under healthy and disease states simulated conditions. Microspheres differed in grade of poly(lactide-co-glycolide) and in the theoretical drug content (i.e. 23 or 30% w/w). Their performance was compared with the commercially available suspension of MP acetate (MPA). Under osteoarthritic state simulated condition, proteins increased the MPA release and reduced the MPA hydrolysis rate, over 48 h. Regarding microspheres, the release patterns over 40 days were significantly influenced by the composition of BSF. The pattern of the release mechanism and the amount released was affected by the presence of proteins. Protein concentration affected the release and the concentration used is critical, particularly given the relevance of the concentrations to target patient populations, i.e. patients with osteoarthritis.

KW - Biorelevant synovial fluids

KW - Corticosteroids

KW - Hyaluronic acid

KW - Intra-articular

KW - Methylprednisolone

KW - Microspheres

KW - PLGA

KW - Proteins

KW - Release testing

UR - http://www.scopus.com/inward/record.url?scp=85063190921&partnerID=8YFLogxK

U2 - 10.1016/j.ejpb.2019.03.019

DO - 10.1016/j.ejpb.2019.03.019

M3 - Article

VL - 139

SP - 115

EP - 122

JO - European Journal of Pharmaceutics and Biopharmaceutics

JF - European Journal of Pharmaceutics and Biopharmaceutics

SN - 0939-6411

ER -